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Abstract
IFN-c activates cells to restrict intracellular pathogens by upregulating cellular effectors including the p65 family of
guanylate-binding proteins (GBPs). Here we test the role of Gbp1 in the IFN-c-dependent control of T. gondii in the mouse
model. Virulent strains of T. gondii avoided recruitment of Gbp1 to the parasitophorous vacuole in a strain-dependent
manner that was mediated by the parasite virulence factors ROP18, an active serine/threonine kinase, and the pseudokinase
ROP5. Increased recruitment of Gbp1 to Drop18 or Drop5 parasites was associated with clearance in IFN-c-activated
macrophages in vitro, a process dependent on the autophagy protein Atg5. The increased susceptibility of Drop18 mutants
in IFN-c-activated macrophages was reverted in Gbp12/2 cells, and decreased virulence of this mutant was compensated in
Gbp12/2 mice, which were also more susceptible to challenge with type II strain parasites of intermediate virulence. These
findings demonstrate that Gbp1 plays an important role in the IFN-c-dependent, cell-autonomous control of toxoplasmosis
and predict a broader role for this protein in host defense.
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Introduction
Toxoplasma gondii is an apicomplexan protozoan parasite with a
broad host range that is capable of causing significant disease in
humans and animals [1]. Many wild or domestic animals serve as
intermediate hosts, becoming infected either by ingestion of
oocysts shed by cats [1], or by carnivorous/omnivorous feeding
that facilitates transmission [2]. Human toxoplasmosis is therefore
zoonotic, with infection caused by ingestion of tissue cysts in
undercooked meat or oocysts that may contaminate food or water
[3,4]. Given the central role of the mouse in the completion of the
life cycle of T. gondii, understanding the mechanisms of immune
control in the mouse are relevant to human infection and may also
identify pathways important in human resistance.
Within North America and Europe, strains of T. gondii are largely
comprised of one of three highly clonal genotypes, referred to as type I,
II, and III [5]. These genotypes have highly different phenotypes in the
laboratory mice, with type I strains being acutely virulent, type II
strains having intermediate virulence, while type III strains are
essentially avirulent [5]. Previous genetic crosses have revealed that
these differences are due to a small number of polymorphic serine/
threonine kinases that are secreted from the rhoptries (ROPs) into the
host cell [6]. Among these ROP18 was identified based on the large
genetic contribution it makes to differences in acute virulence between
highly virulent type I, intermediate virulence type II, and avirulent type
III strains [7,8]. A second locus that contributes more substantially to
acute virulence differences between these strains types encodes a
polymorphic family of pseudokinases called ROP5 [9,10]. Collectively,
these two loci account for the major strain differences in virulence in
the murine model, although other loci have also been implicated in
pathogenesis [6].
Resistance to infection with T. gondii is largely mediated by IL-12
[11] driving expression of IFN-c, which activates both toxoplasma-
static and toxoplasmacidal mechanisms [12], in both hematopoietic
and non-hematopoietic cells [13]. The primary mechanism of cell-
autonomous killing in the mouse is due to IFN-c induced expression
of immunity-related GTPases (IRGs) [14], which are essential for
control of infection in macrophages in vitro [15], and during in vivo
infection with type II strains of T. gondii [16,17]. IRG-mediated
clearance involves the cooperative recruitment and loading of the
GTP-bound IRGs onto the parasitophorous vacuolar membrane
(PVM) surrounding the parasite, with subsequent vesiculation and
rupture of the vacuole, and destruction of the parasite [18,19,20]. A
subset of IRG proteins, known as IRGM proteins modulate the
activation state of the effector IRG proteins [21]: absence of these
IRGM proteins causes spontaneous activation of IRG effectors that
form aggregates, compromising their ability to combat pathogens
[14]. Similarly, cells lacking Atg5 also show disruption in the
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function of IRG proteins, which accumulate as GTP-bound forms
in cytoplasmic aggregates, and hence fail to clear susceptible strains
of T. gondii [22,23]. The accumulation of IRGs on the PVM and the
clearance of parasites in macrophages are blocked by ROP18,
which phosphorylates several IRG proteins, thus preventing their
association with the PVM [24,25].
Although IRGs are expanded in rodents, they are absent or
numerically reduced in many vertebrates including humans, while all
vertebrate groups express members of another interferon-inducible
gene family, the p65 guanylate-binding proteins (GBPs) [14,26]. GBPs
are structurally related to the dynamins and another known antiviral
protein family, the Mx proteins. GBPs range in size from 65–73-kDa
and account for over 20% of the proteins induced after IFN-c
treatment [26,27]. The human genome encodes seven GBPs, while the
mouse contains 13 GBPs including two alternative splice isoforms
[28,29]. It has been reported that type I T. gondii parasites do not
accumulate Gbp1 or Gbp2 on their PVM, while a large percent of
both type II and type III parasites show accumulation of these proteins
[30,31], although the molecular basis for this is unknown. Recent work
has shown that a deletion of a cluster of GBPs on chromosome 3,
including Gbp1, 2, 3, 5, 7 and the splice variant Gbp2ps, increases
susceptibility to type II parasites both in vivo and in vitro [32]. Loss of
Gbp1 or Gbp5 reduced the ability of mice to resist Listeria and
Mycobacteria infection [28,33], and loss of Gbp2 leads to susceptibility to
T. gondii [34]; however, the role of other individual GBPs in the control
of T. gondii has not been explored in vivo.
Here we explored the role of Gbp1 in cell-autonomous resistance
to T. gondii and probed the interaction between known parasite
virulence factors, ROP5 and ROP18, and the GBP pathway. We
also investigate the role for the autophagy protein Atg5 in the
homeostasis and function of GBPs and their interdependence on the
IRG system in controlling resistance to infection with T. gondii.
Results
Gbp1 is recruited to vacuoles containing T. gondii in
ROP5-ROP18 dependent manner
To determine whether the recruitment of GBPs to the PVM
surrounding intracellular parasite is blocked in a ROP18-
dependent manner similar to IRGs, we localized Gbp1 in IFN-
c-activated bone marrow derived macrophages (BMM). The
influence of ROP18 on GBP recruitment was examined using a
previously described transgenic parasites that express ROP18I in
the type III background [8]. Type I parasites (i.e. GT-1 strain)
largely prevented recruitment of Gbp1 (Fig. 1A,B). Similarly, type
III parasites expressing a kinase-active version of ROP18 (i.e.
CTG+ROP18) avoided accumulation of Gbp1 over the first two
hr post infection (Fig. 1A,B). In contrast, a significantly higher
percent of type III vacuoles (i.e. CTG strain) were positively
stained for Gbp1 on the PVM (Fig. 1A,B). The kinase activity of
ROP18 was required to prevent Gbp1 recruitment, as expression
of a kinase dead ROP18 (i.e. CTG+ROP18 D/A) did not prevent
recruitment to the PVM (Fig. 1A,B).
In addition to the active kinase ROP18, it has recently been
shown that the pseudokinase ROP5 is important for acute
virulence of T. gondii [10,35]. Therefore, we examined the role
of these two rhoptry proteins in the prevention of Gbp1
recruitment to the PVM using a loss-of-function approach.
Recruitment of Gbp1 was monitored in IFN-c-activated BMM
infected with type I parasites lacking ROP18 (RHDku80Drop18) or
ROP5 (RHDku80Drop5), vs. the respective complemented strains
(RHDku80Drop18/ROP18 and RHDku80Drop5/ROP5) and the
wild type strain (RHDku80) (Fig. 1C,D). Wild type or comple-
mented parasites expressing ROP18 and ROP5 essentially
prevented Gbp1 accumulation on the PVM, while Drop18
parasites showed significantly higher Gbp1 accumulation. Inter-
estingly, Drop5 parasites showed the highest level of Gbp1
recruitment (Fig. 1C,D). Collectively these data indicate that
known T. gondii virulence factors ROP18 and ROP5 are necessary
to prevent Gbp1 accumulation on the PVM surrounding parasites
in IFN-c-activated macrophages.
Gbp1 recruitment to the parasite containing vacuole is
associated with vesiculation and rupture
IRG proteins have previously been shown to localize to the
PVM surrounding susceptible T. gondii parasites [18,19,24],
although similar findings have not been reported for GBPs.
Cryo-immuno electron microscopy (EM) of IFN-c-activated RAW
264.7 macrophages revealed that Gbp1 was localized diffusely in
the cytosol of cells infected with wild type parasites, and not on the
PVM (Fig. 2A,B). In contrast, Gbp1 strongly localized in the
vicinity of the PV in cells infected with Drop18 parasites (Fig. 2C,D).
Although limited staining was observed on the PVM, Gbp1 was
associated with nearby membrane vesicles that clustered around
the vacuole (Fig. 2E,F). The prominent localization of Gbp1 to
vesicles surrounding the PVM suggests that it may be involved in
delivery of other components to the compartment, or disposal of
membrane following vesiculation and vacuole membrane rupture.
Gbp1 positive vesicles also collect around phagosomes containing
mycobacteria in IFN-c-activated macrophages [28], suggesting
that Gbp1 recruitment could serve as a common protective
mechanism against different pathogen classes.
We also examined the morphological features of the PVM
surrounding susceptible parasites by conventional EM (Fig. 3 A–F).
Vacuoles containing ROP5-deficient (Fig. 3B) or ROP18-deficient
(Fig. 3D) parasites in IFN-c-activated BMM from wild type mice
were slightly distended with an enlarged lumen and showed marked
vesiculation, membrane blebbing, and accumulation of small
vesicles around the PV. In addition, both ROP5 and ROP18
deficient parasites showed evidence of vacuole rupture, leaving the
parasite free in the cytosol, where it often underwent degradation
(Fig. S2). In Gbp12/2 BMM cells activated with IFN-c, vacuoles
containing ROP5-deficient parasites also showed frequent vesicu-
Author Summary
Emerging evidence suggests that the p65 family of
guanylate-binding proteins (GBPs), which is upregulated
by interferon gamma, play an important role in host
defense against intracellular pathogens. We demonstrate
that the ability of virulent strains of Toxoplasma gondii to
avoid recruitment of mouse Gbp1 is mediated by two
parasite virulence factors; the serine threonine kinase
ROP18 and the pseudokinase ROP5, which controls its
activity. GBP proteins required the autophagy protein Atg5
for proper cellular trafficking, recruitment to parasite-
containing vacuoles, and pathogen control, strengthening
the link between innate immunity and autophagy. The
attenuation of mutants lacking ROP18, which show
increased susceptibility to clearance by macrophages and
decreased virulence in mice, was reverted by deletion of
Gbp1, indicating this host factor is needed for resistance to
T. gondii. Collectively, these findings demonstrate a key
molecular interaction between host defenses mediated by
GBPs and parasite virulence factors that thwart innate
immunity. As GBPs are phylogenetically conserved among
vertebrates, including humans, they likely play a broader
role in host resistance.
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Figure 1. Gbp1 is recruited to vacuoles containing T. gondii in a ROP5 and ROP18-dependent manner. (A) Immunofluorescence
localization of Gbp1 on the PVM in IFN-c-activated BMM (10 U/ml IFN-c, 0.1 ng/ml LPS). Images shown are 2 hr post infection with GT-1 (type I), CTG
(type III), CTG+ROP18 (type III expressing ROP18) and CTG+ROP18 D/A (type III expressing kinase-dead ROP18) parasites. Gbp1 was localized with
rabbit polyclonal sera followed by goat anti-rabbit IgG conjugated to Alexa Fluor 488. The vacuole marker GRA5 was detected with mAb Tg 17–113
followed by goat anti-rabbit IgG conjugated Alexa Fluor 594. Scale bar = 5 mm. (B) Quantification of Gbp1 localization to the PVM surrounding the
indicated parasite strains in IFN-c-activated BMMs examined at 2 hr post infection. (C) Immunofluorescence localization of Gbp1 on the PVM in IFN-c-
activated BMM (100 U/ml IFN-c, 0.1 ng/ml LPS) examined at 2 hr post infection. Comparison of type I parasites lacking ROP18 (RHDku80Drop18) or
ROP5 (RHDku80Drop5) vs. the respective complemented strains (RHDku80Drop18/ROP18) and (RHDku80Drop5/ROP5). Gbp1 was localized with rabbit
polyclonal sera followed by goat anti-rabbit IgG conjugated to Alexa Fluor 488. The vacuole marker GRA5 was detected with a mAb Tg 17–113
followed by goat anti-rabbit IgG conjugated Alexa Fluor 594. (D) Quantification of Gbp1 localization to the PVM in IFN-c-activated BMMs
macrophages examined at 2 hr post infection. Strains indicated in (A) compared to the type I parent (RHDku80). Mean 6 S.D.P., n = 3 experiments.
(*P,0.05, Student’s t test).
doi:10.1371/journal.ppat.1003320.g001
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lation accompanied by an enlarged lumen (Fig. 3A), while ROP18-
deficient (Fig. 3C) parasites were found in more a closely-fitting
vacuole surrounded by host cell mitochondria and which had a
smooth circumference, characteristic of an intact PV. Enlargement
of the PVM revealed that membrane blebbing around both ROP5
or ROP18-deficient parasites in wild type cells occurred with a
marked curvature and regular scalloped pattern (Fig. 3 E,F). These
features are highly reminiscent of the previously described
vesiculation of the PV membrane that accompanies IRG-recruit-
ment to the PVM and vacuole destruction [18,23,24]. Notably, this
process is interrupted the Gbp12/2 cells, at least in the terms of the
fate of ROP18-deficient parasites, a result consistent with the
Figure 2. Recruitment of Gbp1 to the parasitophorous vacuole membrane is associated with vesiculation. Cryo-immuno-EM
localization of Gbp1 in IFN-c-activated RAW 264.7 macrophages (10 U/ml IFN-c, 0.1 ng/ml LPS). (A) Distribution of Gbp1 in activated macrophages
infected with wild type T. gondii (T) parasites (RHDku80). Arrow indicates PVM. (B) Enlargement of A showing PVM (arrow). (C–F) Distribution of Gbp1
in IFN-c-activated macrophages infected with ROP18-deficient parasites (RHDku80Drop18). Arrow indicates PVM. (D) Enlargement of C showing PVM
(arrow). (E,F) Distribution of Gbp1 in membrane vesicles in the vicinity of the PVM. Cells were fixed at 2 hr post-infection and immunostained using
rabbit anti-Gbp1 (Rab a Gbp1) polyclonal sera followed by goat anti-rabbit IgG conjugated to 18 nm gold. Scale bars = 500 nm.
doi:10.1371/journal.ppat.1003320.g002
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survival vs. clearance of ROP5 or ROP18-deficient parasites in IFN-
c-activated BMM from wild type vs. Gbp12/2 mice, as described
below.
Gbp1 localization is altered in Atg5-deficient cells
The autophagy protein Atg5 is required for resistance to type II
parasite infection in mice [23], in part due to the fact that in its
absence, members of the IRG family are mislocalized into large
aggregates in the host cell and hence are not recruited to parasite-
containing vacuoles [22,23]. To examine the role for Atg5 in the
localization of Gbp1, we stained IFN-c-activated Atg5-deficient
(Atg5 KO) and wild type (Atg5 WT) mouse embryonic fibroblasts
(MEFs) for Gbp1 and Irga6. In wild type cells, Irga6 showed a
diffuse cytoplasmic distribution (Fig. 4A) and these cells exhibited a
normal homogenous cytosol where Gbp1 was distributed in small
clusters, as shown by cryo-immuno EM (Fig. 4B,C). In contrast, in
the absence of Atg5, Gbp1 was localized to large aggregates within
the cell, and these structures partially co-localized with aggregates
of Irga6 that was in the GTP-bound state (as detected with a
conformation specific antibody) (Fig. 4D,E). Transmission electron
microscopy showed large accumulations of vesicles in the
cytoplasm of Atg5-deficient cells (Fig. 4F,G), which were absent
in the wild type cells (Fig. 3B). Cryo-immuno EM revealed an
accumulation of Gbp1 in clusters of vesicles that accumulated in
the Atg5-deficient cells (Fig. 4H). Gbp1 positive vesicles were
distinct from the endoplasmic reticulum (ER), although they were
interspersed with ER membranes, as indicated by staining for
protein disulfide isomerase (PDI) (Fig. 4H,I).
Figure 3. Ultrastructural features of the parasitophorous vacuole membrane in IFN-c-activated cells. (A–D) Ultrastructural features of
the parasitophorous vacuole (PV) T. gondii (T) in IFN-c-activated (100 U/ml IFN-c, 0.1 ng/ml LPS) BMM from Gbp12/2 or wild type mice infected with
ROP5-deficient (Drop5) or ROP18-deficient (Drop18) parasites. (E–F) Enlargement of the PV surrounding parasites in IFN-c-activated BMM from wild
type mice shows the highly scalloped appearance of the membrane (marked by black arrowheads). Scale bars = 500 nm in A–D, 100 nm in E,F.
doi:10.1371/journal.ppat.1003320.g003
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Figure 4. Gbp1 localization is altered in Atg5-deficient cells. Immunofluorescence localization of Gbp1 and Irga6 in wild type (WT) (A) or
Atg5-deficient (Atg5 KO) (D,E) MEFs activated with IFN-c (10 U/ml IFN-c, 0.1 ng/ml LPS). Gbp1 was localized with rabbit polyclonal sera followed by
goat anti-rabbit IgG conjugated to Alexa fluor 488. Irga6 was localized with mAb 10D7 followed by goat anti-mouse IgG conjugated to Alexa fluor
594. Transmission electron microscopy of wild type (WT) (B) or Atg5-deficient (Atg5 KO) (F,G) IFN-c-activated MEFs. Scale bar = 200 nm. Cryo-immuno-
EM of IFN-c-activated wild type (WT) (C), or Atg5-deficient (Atg5 KO) (H,I), MEFs. Gbp1 was detected with rabbit polyclonal sera (Rab a Gbp1) followed
by goat-anti-rabbit IgG conjugated to 18 nm gold beads and protein disulfide isomerase using mAb antibody 1D3 (Mo a PDI) followed by goat anti-
Gbp1 Mediates Resistance to Toxoplasmosis
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To further assess the composition of the Gbp1 aggregates in the
Atg5-deficient (Atg5 KO) MEFs, we examined their colocalization
with ubiquitin and p62, which were first reported to localize with
Gbp1 in uninfected and mycobacterium-infected macrophages
[28], and also implicated in aggregates of Gbp2 that form in the
absence of IRGM proteins [36]. Immunofluorescence labeling
demonstrated that Gbp1 aggregates largely co-localize with p62
and ubiquitin (Fig. 4J,K); however, the aggregates were LAMP1
negative (Fig. 4L). In comparison, the rare aggregates that also
normally form in wild type cells were typically surrounded by
LAMP1 positive vesicles, suggesting they fuse with lysosomes and
are degraded (Fig. S1). Consistent with this model, the frequency
of IRG-GBP aggregates was substantially increased by treatment
with bafilomycin, which blocks lysosome fusion (Fig. S1). In
bafilomycin treated cells ,20% of cells showed aggregates of
Gbp1 and Irga6 compared to ,1% of DMSO treated cells.
Atg5 is required for the recruitment of Irgb6 and Gbp1 to
parasitophorous vacuoles and clearance in vitro
The altered distribution of Gbp1 and Irga6 in Atg5-deficient
MEFs suggested that recruitment of other IRG members, such as
Irgb6, to the PVM of susceptible parasites might be impaired. To
examine the role of Atg5 in recruitment of Irgb6 and Gbp1 in
BMM, we took advantage of the previously described conditional
deletion strain Atg5flox/flox+LysMcre, in which Atg5 is specifically
ablated in myeloid cells [23]. In IFN-c-activated BMM with
functional Atg5 (Atg5flox/flox), Drop18 or Drop5 parasites showed
increased recruitment of Irgb6 (Fig. 5A) and Gbp1 (Fig. 5B)
compared to the type I wild type or the ROP18 and ROP5
complemented strains. In contrast, BMM lacking functional Atg5
(Atg5flox/flox+LysMcre) showed significantly reduced Irgb6 (Fig. 4A)
and Gbp1 (Fig. 5B) recruitment to all strains. This reversal in
accumulation was particularly evident for Drop18 and Drop5
parasites, which normally show elevated accumulation of Irgb6
[24] and Gbp1 (Fig. 1B). Infection of IFN-c-activated macro-
phages revealed that both Drop18 and Drop5 parasites underwent
enhanced clearance in wild type cells (Atg5flox/flox) (Fig. 5C). This
decrease in survival was reverted to normal in Atg5-deficient
macrophages (Atg5flox/flox+LysMcre) (Fig. 5D). Together, these data
indicate that Atg5 plays an important role in homeostasis of Irgb6
and Gbp1 and in its absence, recruitment of these effectors to the
PVM surrounding susceptible parasites is compromised, prevent-
ing parasite clearance in IFN-c-activated macrophages.
Gbp12/2 cells are defective in parasite clearance and
Irgb6 localization to the PV
To examine the role of Gbp1 in resistance to T. gondii, we first
tested the ability of IFN-c-activated BMM from Gbp1-deficient
mice (Gbp12/2) to clear parasites following overnight infection in
vitro. We infected BMM from C57BL/6 and Gbp12/2 mice with
wild type parasites, which largely resist clearance in activated
macrophages, and Drop18 parasites, which are cleared by ,50%
in activated macrophages [24]. As expected, C57BL/6 BMM
cleared Drop18 parasites to about 50% of the initial infection
(Fig. 6A). Strikingly, Gbp12/2 BMM showed a reduced ability to
clear susceptible Drop18 parasites following overnight incubation,
restoring survival to ,80%, a level that was similar to wild type
parasites in either strain of mice (Fig. 6A). In contrast, the
increased clearance of Drop5 parasites seen in C57BL/6 BMM was
not reversed in Gbp12/2 deficient BMM (Fig. 6A).
Recent studies on the deletion of the Gbpchr3 locus in the mouse
indicated that the ability of IFN-c-activated macrophages to prevent
replication of intracellular parasites, referred to as stasis, is also
compromised in the absence of this locus [32]. Therefore we
examined the ability of activated wild type (C57BL/6) or Gbp12/2
BMM to restrict the intracellular replication ofT. gondii at 20 hr post
infection. Under the activation conditions used here, the majority of
intracellular T. gondii in wild type cells were found in vacuoles
containing 1–2 parasites, with a few having replicated to clusters of 4
(Fig. 6B). In contrast, the majority of intracellular T. gondii were
found in rosettes of 8, with the remainder largely being found in
clusters of 4. Although the level of stasis achieved in wild type cells
was less than that reported previously [32], the ability of Gbp12/2
BMM to control replication was significantly impaired (Fig. 6B).
To examine the kinetics of IRG vs. GBP recruitment, we
examined the percentage of PVs containing ROP18 deficient
parasites that became visibly positive over the first 2 hr post-
infection in BMM. Irgb6 positive vacuoles were elevated at 30 min
post-infection and they remained at similar levels during the first
120 min (Fig. 6C). In contrast, accumulation of Gbp1 was delayed:
the percentage of positive vacuoles was initially lower at 30 min and
only plateaued at 90–120 min (Fig. 6C). Over this time course, the
majority of vacuoles became positive for both Irgb6 and Gbp1
(64.764.2%), while most of the remaining vacuoles stained only
with Gbp1 (33.865.8%), and only a minority being Irgb6 positive
only (262%). Combined with the differences in kinetics, these
findings suggest that Gbp1 is recruited after Irgb6, and that it
remains on the vacuole after Irgb6 is recycled. Alternatively, Gbp1
may have additional IRG-independent mechanisms to target the
PV, as discussed below. Although the percentage of Irgb6 positive
vacuoles remained the same in Gbp12/2 cells at 30 min, it was
significantly reduced at 2 hr when compared to wild type cells
(C57BL/6) (Fig. 6D). In contrast, Irga6 positive PV increased
slightly between 30 min and 2 hr in wild type and did not change in
Gbp12/2 BMM (Fig. 6D). These findings indicate that Gbp1
influences the recruitment and/or retention of some IRG proteins
onto the PVM surrounding susceptible parasites.
To assess the requirement of IRG proteins in the recruitment of
Gbp1 to susceptible parasites, we examined accumulation of Gbp1,
Irgb6, and Irga6 to Drop5 parasites in Irgm32/2 vs. wild type
(C57BL/6) BMM at 2 hr post infection. Similar to previous reports
showing that Irga6 and Gbp2 partially form aggregates in the
cytosol of Irgm32/2 cells [36], we observed that Irga6, Irgb6 and
Gbp1 showed focal clusters of staining in Irgm32/2 cells, although a
majority of the proteins were still homogenously dispersed when
examined by immunofluorescence microscopy (data not shown).
Despite the formation of some aggregates, Gbp1 accumulation on
the PV was not significantly different in Irgm32/2 vs. wild type
BMM, while Irga6 positive PV increased in Gbp12/2 knockout
cells (Fig. 6E). In contrast, the percent of Irgb6 positive PV was
significantly lower in the Irgm32/2 BMM. These data support
previous findings that Irgm3 is required for efficient Irgb6 loading
onto the PV of susceptible parasites [9], but reveal that is not
required for either Irga6 or Gbp1 recruitment. Indirectly this
mouse IgG conjugated to 12 nm gold beads. Scale bar = 200 nm. Immunofluorescence of Gbp1 co-localized with p62 (J), ubiquitin (K), or LAMP1 (L) in
IFN-c-activated MEFs from Atg5-deficient mice (Atg5KO). Gbp1 was localized with rabbit polyclonal sera followed by goat anti-rabbit IgG conjugated
to Alexa fluor 488. p62 was localized with guinea pig polyclonal sera followed by goat anti-guinea pig IgG conjugated to Alexa Fluor 594. Ubiquitin
was localized with mAbFK2 followed by goat anti-mouse IgG conjugated to Alexa fluor 594. LAMP1 was localized with rat mAB 1D4B followed by
goat anti-rat 1gG conjugated to Alexa fluor 594. Image in L is a deconvolved Z slice, all other fluorescence images are wide field. Scale bars = 5 mm.
doi:10.1371/journal.ppat.1003320.g004
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implies that Irgb6 is also not required for Gbp1 recruitment to the
PVM. Collectively, these results demonstrate that Gbp1 is critical
for the control and clearance of T. gondii in IFN-c-activated BMM in
vitro, and suggests that it while it works cooperatively with the IRGs,
it may not depend on them for recruitment.
Gbp1-deficient mice are significantly more susceptible to
challenge with moderately virulent T. gondii
Next we wanted to examine how Gbp1 deficiency would affect
in vivo challenge with parasites. We challenged C57BL/6 and
Gbp12/2 mice with highly virulent type I strain RH vs. ROP18-
deficient parasites and monitored their survival. Drop18 parasites
showed a significantly delayed time to death compared with wild
type parasites in wild type mice (Fig. 7A). The deficiency of Drop18
parasites was partially reversed in Gbp12/2 mice, which
succumbed to challenge 4 days earlier than C57BL/6 mice
(Fig. 7A). When challenged with the highly virulent wild type
parasites, Gbp12/2 mice showed almost equivalent survival to
C57BL/6 mice, although this is not unexpected given the high
virulence of type I strains (Fig. 7A). Additionally, the highly
Figure 5. Cells lacking Atg5 are unable to recruit Irgb6 or Gbp1 to the parasitophorous vacuole or clear susceptible parasites. (A)
Quantification of Irgb6 localization to the parasitophorous vacuoles surrounding intracellular parasites in IFN-c-activated BMM (50 U/ml IFN-c, 0.1 ng/
ml LPS) from Atg5flox/flox or Atg5flox/flox+LysMCre mice. Means 6 S.D., n = 6 samples from 2 combined experiments. (**P,0.005, Student’s t test). (B)
Quantification of Gbp1 recruitment to the parasitophorous vacuoles surrounding intracellular parasites IFN-c-activated BMM (100 U/ml IFN-c, 0.1 ng/
ml LPS) from Atg5flox/flox or Atg5flox/flox+LysMcre mice. Representative experiment from three independent experiments with similar outcomes. Mean
6 S.D., n = 3 replicates per group. (*P,0.05, Student’s t test). In vitro clearance of parasites in IFN-c-activated BMM (50 U/ml IFN-c, 0.1 ng/ml LPS)
from Atg5flox/flox (C) or Atg5flox/flox+LysMcre (D) mice. Means 6 S.D., n = 6 samples from 2 combined experiments. (*** P,0.001, Student’s t test).
doi:10.1371/journal.ppat.1003320.g005
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Figure 6. Gbp1 is necessary for control of T. gondii. (A) In vitro clearance of ROP18-deficient (RHDku80Drop18), ROP5-deficient (RHDku80Drop5)
and wild type (RHDku80) T. gondii in IFN-c-activated BMM (50 U/ml IFN-c, 10 ng/ml LPS) from Gbp12/2 or C57BL/6 mice. Parasites were visualized
using mAb to SAG1 (DG52) directly conjugated to Alexa Fluor 594. Percent of cells infected at 20 hr compared to 30 min time point. Mean 6 S.D.P.,
n = 3–4 experiments (*P,0.005, Student’s t test). (B) Analysis of replication in IFN-c-activated BMM (as in A) infected with wild type (RHDku80)
parasites and analyzed at 20 hr post-infection. Mean number of parasites per vacuole 6 S.D. n = 2 (*P,0.05, **P,0.005, ***P,0.0005,
**** P,0.000005, Student’s t test). (C) Quantification of Irgb6 and Gbp1 localization to parasitophorous vacuoles of intracellular parasites in IFN-c-
activated BMM (100 U/ml IFN-c, 0.1 ng/ml LPS) infected with ROP5-deficient (RHDku80Drop5) parasites. Mean 6 S.D. n = 6 samples from 2 combined
experiments. (D) Quantification of Irgb6 and Irga6 localization to parasitophorous vacuoles surrounding ROP18-deficient (RHDku80Drop18) parasites
in C57BL/6 vs. Gbp12/2 BMM activated with 100 U/ml IFN-c and 0.1 ng/ml LPS. Cells were infected for 30 min vs. 2 hr, fixed, permeabilized and
stained using rabbit anti-Irgb6 and mAb against GRA5, or mAb 10D7 against Irga6 and rabbit anti-GRA7, and detected using corresponding Alexa
Flour secondary antibodies. Representative of two experiments with similar outcomes. Mean 6 S.D.P, n = 4. (*P,0.05, Student’s t test). (E)
Quantification of Gbp1, Irgb6 and Irga6 localization to parasitophorous vacuoles of ROP5-deficient parasites (RHDku80Drop5) in C57BL/6 vs. Irgm32/2
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attenuated phenotype of the Drop5 parasites in mice was not
reversed in Gbp12/2 mice (data not shown), consistent with the
enhanced clearance of this parasite mutant in Gbp12/2 cells in
vitro, both of which reflect much more severe defect in this mutant,
as described previously [9].
To further explore the defect in resistance, we challenged
Gbp12/2 and C57BL/6 mice with a moderately virulent type II
parasite strain at two different doses and monitored their survival
for 60 days. C57BL/6 mice were largely resistant to infection with
type II parasites, with a single mouse succumbing to infection at
day 13 post infection with 1,000 parasites (Fig. 7B). Gbp12/2 mice
were more susceptible to type II parasites with animals starting to
succumb to challenge 3 days earlier than C57BL/6 mice.
Additionally, significantly fewer Gbp12/2 mice survived challenge
with either 500 or 1,000 parasites (Fig. 7B).
The delayed death phenotype of Gbp12/2 mice is reminiscent
of type II infection in Nos22/2 mice, which succumb due to
encephalitis [37]. Therefore, we examined the brains of surviving
C57BL/6 and Gbp12/2 animals at day 60 days post infection for
signs of encephalitis by H&E staining. Sections from the brain of
an infected C57BL/6 mouse showed mild perivascular cuffing,
minimal focal accumulation of lymphocytes, and a single tissue
cyst (Fig. 7C, D). Sections from the brain of an infected Gbp12/2
mouse showed more severe pathological changes including
moderate focal gliosis, multifocal perivascular cuffing, moderate
thickening of the meninges, and multiple tissue cysts (Fig. 7 E,F).
Collectively, these results demonstrate that Gbp1 plays an
important role in the control of infection in vivo as Gbp1-deficent
animals show increased susceptibility both during acute and
chronic infection.
Discussion
IFN-c plays a crucial role in activating cells to control
proliferation and destroy intracellular parasites. Here we demon-
strate that Gbp1 plays an important role in this cell-autonomous
control in vitro and in resistance to T. gondii infection in vivo. GBPs
may work cooperatively with IRGs, which have previously been
implicated in resistance to T. gondii, and both families of effectors
rely on Atg5 for homeostasis. Our work underscores the
importance of the GBPs in resistance in the mouse, and suggests
that they may have similar roles in other hosts, including humans.
Previous studies have shown that Gbp1, Gbp2, Gbp3, Gbp6,
Gbp7, and Gbp9 are recruited to PV containing T. gondii in IFN-
c-activated MEFs or RAW 264.7 macrophages and that the type I
BK strain avoids recruitment of a subset of these (i.e. Gbp1, Gbp2,
Gbp3, and Gbp6) [30]. Similar findings were reported using MEFs
transfected with an epitope-tagged version of Gbp1 that was
recruited to PV containing type II (Pru strain) and type III (CEP
strain), but not type I (RH strain) parasites [31]. This later study
also made use of transgenic type III strain parasites that express
the type 1 allele of ROP18, which enhances virulence, and found
that this resulted in decreased recruitment of Gbp1 [31]. Here, we
confirm and extend these findings by showing that the virulent
type I GT-1 strain blocks recruitment of Gbp1, while PV
containing avirulent type III (CTG) parasites accumulated this
effector protein. We also show that the ability of ROP18 to confer
protection on the normally susceptible type III strain CTG
depends on the kinase activity, as parasites expressing a kinase
dead form of ROP18 (CTG+ROP18 D/A) accumulated Gbp1 at
levels slightly higher than CTG alone. Further, type I mutants
lacking either ROP18 or ROP5 were also susceptible to
recruitment of Gbp1, a phenotype that was fully complemented
by re-expression of the respective virulence factors.
ROP18 has previously been shown to affect survival in IFN-c-
activated macrophages, a process that occurs due to selective
phosphorylation of IRG proteins, thereby blocking GTPase
activity and disrupting vacuole recruitment [24,25]. In contrast,
ROP5 functions by disrupting oligomerization of Irga6 [38,39],
and/or by directly enhancing the catalytic activity of ROP18 [9].
The mechanisms by which the virulent alleles of ROP5 and
ROP18 prevent GBP accumulation are presently uncertain but
may involve similar functions. Gbp1 and Gbp2 have been shown
to form tetramers in response to GTP binding, leading to
cooperative activation of GTPase activity [28,40]. Mutants in
the GTP binding domain of Gbp2 that block GTPase activity and
alter formation of multimers, disrupts loading onto PV containing
susceptible T. gondii [40], while similar mutations in Gbp1 impairs
control of both Listeria and Mycobacteria [28]. Whether GBPs are a
direct target of ROP18 phosphorylation is presently unknown,
although they contain regions similar to the described motif of
ROP18 [24]. Further studies designed to elucidate the mecha-
nisms by which ROP5 and ROP18 disrupt GBP recruitment are
currently underway.
Previous kinetic studies of IRG recruitment to PV containing
susceptible parasites shows that Irgb6 and Irgb10 arrive early,
followed by other IRG proteins such as Irga6 [22]. Given their
previously established importance in the clearance process, Irga6
[41] and Irgb6 [24] were used here as sentinels of this pathway.
Previous studies have shown that PV containing susceptible
parasites are rapidly stripped of their membrane and the parasite
within the vacuole is digested [22]; hence, the percentage of IRG
positive vacuoles at any given time point reflects only a portion of
the parasites that ultimately are destroyed in the overnight
clearance assay. Our findings are consistent with this model in
that we observed efficient loading of Irgb6 at early time points
(30 min) and the level increased slightly over the first 2 hr,
consistent with previous reports [23,24]. Others have reported that
Irgb6 accumulation to vacuoles containing susceptible parasites
(i.e. CTG) is decreased in cells lacking the Gbpchr3 locus [32].
Here, we show that the initial recruitment of Irgb6 is normal at
30 min, but the retention of this marker is impaired with fewer PV
remaining positive at 2 hr. Combined with the finding that Irgb6
co-precipitates with Gbp1–5 [32], this suggests that accumulation
of GBPs is associated with stabilization of IRGs and their retention
on the vacuole membrane. Whether GBPs contribute directly to
membrane blebbing and physical disruption of the PVM, or
modulate the function of other effectors at this interface, remains
to be demonstrated by further studies. Together these data
suggests that destruction of the PV in response to IFN-c requires a
sequential recruitment of both IRG and GBP proteins, ultimately
resulting in membrane disruption.
Autophagy proteins also participate in cell autonomous
clearance of parasites, although these may be due to indirect
effects on the homeostasis of effectors such as IRGs and GBPs.
Utilizing Atg5-deficient MEFs, we examined the localization of
Gbp1 in IFN-c-activated cells. Immunofluorescence and electron
microscopy showed that Atg5-deficient cells have large mem-
brane-associated aggregates of Gbp1 in their cytoplasm and that
these co-localize with the active GTP-bound form of Irga6,
BMM activated with 100 U/ml IFN-c and 0.1 ng/ml LPS. Representative experiment from 2–3 independent experiments with similar outcomes. Mean
6 S.D., n = 3 replicates per group. (*P,0.05, **P,0.005, Student’s t test).
doi:10.1371/journal.ppat.1003320.g006
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ubiquitin, and the autophagy adaptor protein p62. Although, they
do not co-localize with LAMP1 in Atg52/2 cells, they do proceed
to autophagolysosomes in wild type cells and Gbp1 co-immuno-
precipitates p62 from cell lysates in a manner that does not require
the p62 ubiquitin-binding domain [28]. Similarly, previous studies
have also shown that in the absence of IRGM proteins, both IRG
Figure 7. Gbp1-deficient animals are more susceptible to T. gondii infection. (A) Survival of Gbp12/2 or C57BL/6 mice s.c. infected with 100
ROP18-deficient (RHDku80Drop18) or wild type (RHDku80) parasites. Two independent experiments combined, n = 8 mice per parasite strain for
C57BL/6 and n=10 mice per parasite strain for Gbp12/2. (***P,0.0005, Gehan-Breslow-Wilcoxon Test). (B) Survival of Gbp12/2 or Combination of
two experiments where n = 8–9 animals per group. (** P,0.005, Gehan-Breslow-Wilcoxon Test). (C–F) H&E paraffin sections from the thalamus region
of the brains from representative surviving mice (from B) at 60 days post infection. Scale bars = 100 nm.
doi:10.1371/journal.ppat.1003320.g007
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and GBP proteins form co-aggregates that colocalize with the
adaptor p62 and the autophagy protein LC3 [36]. Collectively,
these results suggest that autophagy is necessary for removal of
aggregates that spontaneously form in wild type cells, and which
are degraded by a classical autophagy pathway that terminates in
lysosomal fusion.
The aberrant localization of Gbp1 in Atg5-deficient cells
provided an opportunity to examine the functional consequences
of this disruption on parasite clearance in macrophages that were
selectively deleted for Atg5 using LysMcre recombination.
Recruitment of both Irgb6 and Gbp1 to susceptible parasites
(RHDku80Drop18 and RHDku80Drop5) was significantly reduced in
BMM lacking Atg5. Additionally, clearance of these susceptible
parasite strains was almost completely reversed in Atg5-deficient
BMM. These effects are most likely due to the aberrant
localization of IRGs and GBPs that occurred in the absence of
Atg5. Improper localization of IRGs and GBPs may be due to a
requirement for autophagy to remove misfolded aggregates that
otherwise drive inappropriate activation. Interestingly, we have
observed a similar requirement for Atg7 and Atg16 in cell-
autonomous control of T. gondii in IFN-c-activated BMM in vitro,
although this requirement may not extend to all mediators of the
autophagy pathway (S. Hwang and H.W. Virgin, unpublished).
Alternatively, the requirement for Atg5 may not reflect a classical
autophagy degradation pathway, but rather a role in the delivery
of effectors to pathogen containing vacuoles, as suggested by the
membranous accumulations that occur in the proximity of PV that
are targeted for destruction (Figure 2, 3 present study, and
[23,28]). Consistent with this, GBPs are localized to membrane
vesicles within the cytoplasm of host cells, and several contain a C-
terminal CaaX box allowing for isoprenylation that facilitates
interaction with host cell membranes [28,30]. Regardless of the
exact role of Atg proteins, this illustrates the critical balance of
control of these two families of effectors, which are maintained in
an inactive state in order to avoid damage to host membranes, yet
need to be readily mobilized for pathogen clearance.
Previous work has shown that a genetic knockout of the Gbpchr3
locus increases susceptibility to a type II strain T. gondii, which has
an intermediate level of virulence in the mouse [32]. Analyzing the
phenotype of this mutant is complicated due to the simultaneous
disruption of five intact genes as well as a truncated form of Gbp2.
Characterization of this mouse revealed that it has normal
expansion of CD4+ and CD8+ T cells, and produces normal
levels of IL-12 and IFN-c following infection with T. gondii [32].
Macrophages from these Gbpchr32/2 mice also produce normal
levels of O2
2 and NO in response to IFN-c [32]. Despite having
intact responses, IFN-c-activated BMM from these animals show
specific defects in the control of T. gondii replication (stasis), as well
as ability to clear parasites (clearance) in vitro. This former
phenotype suggests that GBPs play a role in the NO-mediated
stasis that impairs parasite replication, while the later defect is due
to decreased recruitment of Irgb6 and an inability to vesiculate
and destroy PV [32]. Reconstitution experiments suggested that
Gbp 1, 5 and 7 contribute to this clearance defect in vitro, although
the over-expression strategy used in this study complicates the
interpretation of these findings.
In the present work, we have examined a single knockout of
Gbp1 to address the role of this protein in resistance to T. gondii.
We observed that both the ability to induce stasis and the capacity
for clearance of susceptible parasites in vitro was greatly reduced in
IFN-c-activated macrophages from Gbp12/2 vs. wild type mice.
Hence, the phenotype of BMM from the Gbp12/2 mouse
partially recapitulates the two major defects seen in cells from the
Gbpchr3 deletion mouse when tested in vitro. Greater susceptibility
was also seen in vivo, with Gbp12/2 mice succumbing to infection
earlier with Drop18 parasites, which are partially attenuated in
virulence towards wild type mice. Furthermore, Gbp1 was
important for resistance to challenge with an intermediate
virulence, type II strain of T. gondii, with the majority of mice
succumbing after the initial acute infection. Surviving Gbp12/2
mice showed elevated CNS pathology consistent with encephalitis
as the cause of death. Recent studies using a single gene deletion of
Gbp22/2 also reported loss of the ability to control replication in
vitro and increased susceptibility to type II strain challenge during
the chronic phase [34]. The increased chronic susceptibility of
Gbp12/2 or Gbp22/2 mice is similar to that previously described
for Nos22/2 mice, which lack inducible nitric oxide synthase and
hence produce lower levels of NO [37]. However, Gbpchr32/2
mice produce normal levels of NO when stimulated with IFN-c,
despite losing the capacity to control parasite replication in vitro.
Hence, the increased susceptibility in Gbp12/2 or Gbp22/2 mice
to chronic infection may reflect reduced NO production locally
within the CNS, or result from impaired clearance via the IRG or
GBP pathways, leading to higher chronic burdens of infection.
GBPs have recently been implicated in resistance to several
pathogens in the mouse and yet they likely play overlapping yet
different roles with respect to individual pathogens [26]. Gbp12/2
and Gbp52/2 mice were first shown to be important for control of
Listeria and Mycobacteria infections [28,33]. Individual deletion of
Gbp2 [34] or Gbp1 (present report), renders mice susceptible to T.
gondii, while additional genes within the Gbpchr3 locus may likewise
contribute since the phenotype of this deletion is more severe than
any of the single mutants [32]. In contrast, individual deletion of
Gbp2ps, an alternatively spliced variant, or of Gbp5 does not
affect susceptibility to i.p. challenge with type II ME49 parasites
[32]. The diversity of GBPs may be an adaptation to target
different intracellular pathogens: availability of additional gene
disruptants will facilitate further testing of the role of individual
GBPs in resistance to a variety of pathogens. As well, the diverse
nature of pathogens affected by GBPs suggest that they play
indirect roles in affecting delivery of other effectors, as reported
previously for control of intracellular bacterial pathogens [28], or
the retention of Irgb6 to T. gondii vacuoles as shown here, and
reported previously [32].
Although studies on GBPs conducted to date have focused on
their role in resistance in the mouse, this family of proteins is
highly conserved in vertebrates [42] and even some protochor-
dates [33]. Several studies have examined their participation in
resistance to infection in humans. Human GBP1 has been shown
to contribute to anti-viral activity against vesicular stomatitis virus
and encephalomyocarditis virus [43] and hepatitis C [44], and
recent studies implicate hGBP3 in resistance to influenza [45].
Previous work examining the role of GBPs in human cells show
that GBP1 is recruited to the inclusion membrane of Chlamydia
and over-expression contributes to smaller inclusion size [46]. The
conservation of this family of proteins in humans and other higher
order mammals [26] suggests that the GBPs play a more
widespread role in resistance to infection.
Materials and Methods
Parasite strains and culture
Type I (GT-1), type III transfection control (CTG Ble), type III
parasites expressing ROP18 clone V1 (CTG+ROP18) and type III
parasites expressing a kinase-dead ROP18 clone L1
(CTG+ROP18 D/A) were described previously [8]. Type I
RHDku80DHx (RHDku80) parasites described previously [47],
were used here as wild type. Type I parasites lacking ROP18
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(RHDku80Drop18) [24] and the complemented strain (RHDku80-
Drop18/ROP18) [35], were described previously. A type I parasite
strain lacking ROP5, (RHDku80Drop5) and the complemented
strain (RHDku80Drop5/ROP5) were described previously [35].
Luciferase expressing parasites were generated by transfection of
parasites with pClickluc, as described previously [48] and isolation
of single cell clones. Type II Prugnaud strain parasites expressing
firefly luciferase and GFP (PRU-Luc-GFP) were provided by John
Boothroyd (Stanford University). Parasites were cultured in human
foreskin fibroblasts grown in DMEM supplemented with 10% fetal
bovine serum (HyClone, Thermo Scientific, Rockford, IL), 2 mM
glutamine, 10 mM HEPES pH 7.5 and 20 mg/ml gentamicin at
37uC under 5% CO2. For all experiments, parasites were allowed
to naturally egress and harvested shortly thereafter as described
previously [49].
Ethics statement
All animal experiments were conducted according to the U.S.A.
Public Health Service Policy on Humane Care and Use of
Laboratory Animals. Animals were maintained in an AAALAC-
approved facility and all protocols were approved by the
Institutional Care Committee (School of Medicine, Washington
University in St. Louis).
Animal studies
CD-1 and C57BL/6 mice were obtained from Charles River
Laboratory (Wilmington, MA). Gbp12/2 mice, originally derived
on a 129 background and backcrossed 6–8 times to C57BL/6,
were provided by the MacMicking laboratory as described
previously [28], and bred locally. Atg5flox/flox (control) mice and
Atg5flox/flox+LysMcre mice (8–12 weeks old) provided by the Virgin
laboratory were bred locally and genotyped as described [23].
Irgm32/2 mice on a C57/BL6 background were provided by
Greg Taylor (Taylor et al., 2000), and bred locally. For in vivo
challenges with type I strains, 8–12 week old female C57BL/6 and
Gbp12/2 mice were infected s.c. with 100 freshly egressed
parasites and survival was monitored for 30 days as described
[8,49]. For in vivo challenges with PRU-Luc-GFP parasites, 8–12
week old (male and female, matched per group) C57BL/6 and
Gbp12/2 mice were infected i.p. with either 500 or 1,000 freshly
egressed parasites and survival was monitored for 60 days.
Cell culture
Bone marrow-derived macrophages (BMMs) and RAW 264.7
macrophages were cultured as described previously [24]. Immor-
talized MEFs were cultured in DMEM supplemented with L-
glutamine and 10% FBS. Where indicated, cells were activated by
treatment with murine recombinant IFN-c (R&D Systems,
Minneapolis, MN) and LPS (E. coli O55:B5) (Sigma-Aldrich, St.
Louis, MO) for 18–24 hr before use.
Antibodies
The PVM was localized with mouse mAb anti-GRA5 Tg17–
113 [50], or rabbit polyclonal sera to GRA7 [51]. Intracellular T.
gondii parasites were localized with either mouse mAb anti-SAG1
DG52 or rabbit polyclonal sera to RH strain tachyzoites. Gbp1
and was localized with rabbit polyclonal sera raised against
peptides specific to each protein [30]. Irgb6 was localized with
rabbit anti-Irgb6 [52] or goat anti-TGTP (Santa Cruz Biotech-
nology, Dallas, TX) as indicated. Irga6 was localized with mouse
mAb 10D7, which recognizes the GTP bound form. p62 was
localized with guinea pig polyclonal antibody specific to the C-
terminus (Progen, Heidelberg, Germany). Ubiquitin was localized
with mouse mAb FK2 (EMD Millipore Corporation, Billerica,
MA). LAMP1 was localized with rat mAb ID4B, obtained from
the Developmental Studies Hybridoma Bank (http://dshb.
biology.uiowa.edu). Secondary antibodies conjugated to Alexa
Fluor 488 or 594 (Invitrogen, Grand Island, NY) were used for
detection by immunofluorescence.
Immunofluorescence assays
Cells for immunofluorescence were fixed in 4% formaldehyde,
permeabilized with 0.05% saponin, and stained using primary and
secondary antibodies as described previously [24]. Samples were
visualized using a Zeiss Axioskop 2 MOT Plus microscope
equipped for epifluorescence and using a 636 PlanApochromat
lens, N.A. 1.40 (Carl Zeiss, Inc., Thornwood, NY). Images were
acquired with an AxioCam MRm camera (Carl Zeiss, Inc.) using
Axiovision v4.6, and processed using similar linear adjustments for
all samples in Photoshop CS4 v9. For deconvolution, images were
acquired as above using automatic Z-stack acquisition in
Axiovision and deconvolved using the nearest neighbor algorithm.
Cellular recruitment assays
To examine the distribution of host cellular proteins, samples
were fixed between 30 min to 2 hr post infection (see legends for
specific details). After staining with appropriate primary and
secondary antibodies, recruitment was determined by first
visualizing the parasitophorous vacuole or parasite marker, then
assessing whether there was an accumulation of host protein
around each parasite. The percentage of positive parasites was
determined from 10 representative fields that were examined at
636.
Intracellular clearance and replication assays
To examine intracellular clearance, IFN-c-activated macro-
phages were infected with freshly egressed parasites, and then
either fixed at 30 min post infection, or returned to culture in
complete medium for 20 hr. Clearance was assessed by comparing
the percentage of cells infected at 30 min vs. those remaining after
20 hr, as described previously [24]. For 3 biological replicates, 10
fields were counted on each of three coverslips that were examined
at 636. To examine intracellular replication, BMM were activated
with IFN-c and infected with wild type parasites for 30 min,
washed to remove extracellular parasites, and recultured overnight
in complete medium. At 20 hr post infection, cells were fixed,
permeabilized as above, and visualized using mAb to SAG1
(DG52) directly conjugated to Alexa Fluor 594. The number of
parasites per vacuole was determined from counting 100 vacuoles
per sample from three separate coverslips. In general, 15–30% of
cells were singly infected at 30 min. In order to combine
experiments with different initial infection rates, the data were
normalized by expressing the infection rate at 20 hr as a
percentage of the infection rate at 30 min.
Transmission electron microscopy
Samples for EM were activated with IFN-c and LPS for 18–
24 hr. Where indicated, cells were infected with freshly egressed
parasites for 30 min, washed three times with PBS then fixed at 2
and 6 hr post infection. For ultrastructural analysis, cells were
fixed in 2% paraformaldehyde/2.5% glutaraldehyde (Polysciences
Inc., Warrington, PA) in 100 mM phosphate buffer, pH 7.2 for
1 hr at room temperature, processed and examined as described
previously [23,24]. For immuno-EM, cells were fixed in 4%
paraformaldehyde/0.05% glutaraldehyde (Polysciences Inc.,) in
100 mM PIPES/0.5 mM MgCl2, pH 7.2 for 1 hr at 4uC, and
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processed as described previously [24]. Sections were stained with
mouse anti-protein disulfide isomerase (Enzo Life Sciences, Inc.
Farmington, NY) and rabbit anti-Gbp1 antibodies for 1 hr at
room temperature, followed by gold-conjugated secondary anti-
bodies (Jackson ImmunoResearch Laboratories, Inc., West Grove
PA). Sections were stained and viewed with a JEOL 1200EX
transmission electron microscope (JEOL USA Inc., Peabody,
MA), as described previously [24]. Parallel controls omitting
primary antibodies were consistently negative at the concentration
of colloidal gold conjugated secondary antibodies used in these
studies.
Histological studies
Animals were sacrificed at 60 days post infection; the brain was
removed and fixed in 10% neutral- buffered formalin. Tissues
were dehydrated in ethanol and embedded in paraffin, and
5 micron sections were stained with hematoxylin and eosin (H&E).
Sections were evaluated by veterinary pathologist in the Depart-
ment of Comparative Animal Medicine, Washington University.
Statistics
Statistical analyses were conducted using Microsoft Excel and
PRISM. Excel results were compared using the Student’s t tests
performed under the assumption of equal variance and with a two-
tailed test where P#0.05 was considered significant. Survival
statistics were compared using log-rank and Gehan-Breslow-
Wilcoxin tests in PRISM. Data were graphed as means 6
standard deviation of the population (S.D.P.), or as standard
deviation (S.D.), as noted.
Supporting Information
Figure S1 Localization of Gbp1 aggregates with ubiquitin, p62,
or LAMP1 in wild type murine embryonic fibroblasts (MEFs). (A–
C) Immunofluorescence of untreated wild type (Atg5 WT) MEFs
activated with IFN-c and LPS (100 U/ml and 0.1 ng/ml
respectively) for 18 hours. Gbp1 localized with rabbit polyclonal
sera followed by goat anti-rabbit IgG conjugated to Alexa Fluor
488. (A) Ubiquitin was localized with mAbFK2 followed by goat
anti-mouse IgG conjugated to Alexa fluor 594. (B) p62 was
localized with guinea pig polyclonal sera followed by goat anti-
guinea pig IgG conjugated to Alexa Fluor 594. (C) LAMP1 was
localized with rat mAB 1D4B followed by goat anti-rat 1gG
conjugated to Alexa fluor 594. (D–E) Wild type Atg5 MEFs were
treated with 1 mM Bafilomycin (Invivogen, San Diego, CA)
concurrent with IFN-c and LPS activation (100 U/ml, 0.1 ng/
ml respectively) for 18 hr. (D) Ubiquitin was localized with mAb
FK2 followed by goat anti-mouse IgG conjugated to Alexa fluor
594. (E) p62 was localized with guinea pig polyclonal sera followed
by goat anti-guinea pig IgG conjugated to Alexa Fluor 594. Scale
bar = 5 mm, similar scale for all images. In all panels, cells were
permeabilized with 0.05% saponin, blocked with 5% FBS, 5%
normal goat serum in 0.05% saponin, and washed with 1%
normal goat serum in 0.01% saponin. Samples were stained with
primary and secondary antibodies and mounted in ProLong Gold
antifade reagent with DAPI (Molecular Probes, Eugene, OR), as
described in the methods. Samples were visualized using a Zeiss
Axioskop 2 MOT Plus microscope equipped for epifluorescence
and using a 636PlanApochromat lens, N.A. 1.40 (Carl Zeiss, Inc.,
Thornwood, NY). Images were acquired with an AxioCam MRm
camera (Carl Zeiss, Inc.) using Axiovision v4.6. Images in panels
A,B, D, and E are wide field epifluorescence. Images in C were
acquired using automatic Z-stack acquisition in Axiovision and
deconvolved using the nearest neighbor algorithm. A representa-
tive central slice was exported to Photoshop and adjusted using
similar settings.
(TIF)
Figure S2 Ultrastructural features of the parasitophorous
vacuole membrane of parasites that have undergone vacuole
blebbing, stripping and death in the cytoplasm of IFN-c-activated
bone marrow derived macrophages from wild type mice infected
with ROP5-deficient (RHDku80Drop5) or ROP18-deficient
(RHDku80Drop18) parasites. (A–C) ROP5-deficient parasites with
vacuole membranes that showed blebbing (A), vacuole stripping
(B) and parasite death (C). Similar ultrastructrual features are seen
for ROP18-deficient parasites (D–F). Scale bars = 500 nm.
Samples for EM were activated with 50 U/ml IFN-c and
10 ng/ml LPS for 18–24 hr. Cells were infected with freshly
egressed parasites for 30 min, washed three times with PBS then
fixed at 2 to 6 hr post infection. For ultrastructural analysis, cells
were fixed in 2% paraformaldehyde/2.5% glutaraldehyde (Poly-
sciences Inc., Warrington, PA) in 100 mM phosphate buffer,
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